Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors

Artikel in diesem Heft

1. Publisher's Note
2. Publisher's Note
3. Editorials
4. Full-Disclosure in Industry-Sponsored Laboratory Medicine Research Studies: Statement by the Consortium of Laboratory Medicine Journal Editors
5. Association of malignant mesothelioma and asbestos related conditions with ovarian cancer: shared biomarkers and a possible etiological link?
6. Pharmacogenomics of alcohol metabolism: implications for legal testing
7. Reviews
8. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine
9. Application of proteomics to prenatal screening and diagnosis for aneuploidies
10. Opinion Paper
11. Harmonization of free thyroid hormone tests: a mission impossible?
12. Genetics and Molecular Diagnostics
13. A polymorphism in the 5’ UTR of the DEFB1 gene is associated with the lung phenotype in F508del homozygous Italian cystic fibrosis patients
14. Interaction between COX-2 G-765C and smoking in relation to coronary artery disease in a Chinese Uighur population
15. General Clinical Chemistry and Laboratory Medicine
16. Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysis
17. Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical application
18. A high-performance liquid chromatographic method for benznidazole quantitation in plasma of patients with Chagas disease
19. Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies
20. Interlaboratory study of free monoclonal immunoglobulin light chain quantification
21. Serum zinc-α₂-glycoprotein concentrations in patients with non-alcoholic fatty liver disease
22. Testosterone is an independent determinant of bone mineral density in men with type 2 diabetes mellitus
23. Introduction of a new cobalamin (vitamin B12) assay: lessons from a flawed validation study
24. Prevalence and course of pseudothrombocytopenia in outpatients
25. Use of the CD19 count in a primary care laboratory as a screening method for B-cell chronic lymphoproliferative disorders in asymptomatic patients with lymphocytosis
26. Validation and Outcome Studies Reference Values and Biological Variations
27. Age- and gender-dependent changes in circulating concentrations of tumor necrosis factor-α, soluble tumor necrosis factor receptor-1 and sulfated glycosaminoglycan in healthy people
28. Gender-specific association of serum uric acid with metabolic syndrome and its components in juvenile obesity
29. Cross-sectional study of biomarkers of exposure and biological effect on monozygotic twins discordant for smoking
30. Cancer Diagnostics
31. Evaluation of ovarian cancer biomarkers in subjects with benign asbestos-related pleural diseases
32. Development of a fluorescent microsphere immunoassay for cystatin B (CSTB) in serum of patients with hepatocellular carcinoma
33. Letters to the Editor
34. Factors reducing hemolysis rates in blood samples from the emergency department
35. Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
36. Crystal-associated pseudoeosinophilia of synovial fluid